Health CanadaGeneral Alert
Health Canada has Suspended Market Authorization of ADDERALL XR™ (Amphetamine Salts), a Drug Approved for Attention Deficit Hyperactivity Disorder (ADHD) in Children
Published: February 11, 2005Recall ID: 24396Category: generalCountry: Canada
Safety AlertHealth CanadaCanada
CanadaHealth Canada has Suspended Market Authorization of ADDERALL XR™ (Amphetamine Salts), a Drug Approved for Attention Deficit Hyperactivity Disorder (ADHD) in Children
Recalling Firm: Marketed health products
Reason for Recall / Hazard
New safety information
Product Description & Identification
Health Canada has Suspended Market Authorization of ADDERALL XR™ (Amphetamine Salts), a Drug Approved for Attention Deficit Hyperactivity Disorder (ADHD) in Children
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24396 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/health-canada-has-suspended-market-authorization-adderall-xrtm-amphetamine-salts-drug |
| Issue | New safety information |
| Title | Health Canada has Suspended Market Authorization of ADDERALL XR™ (Amphetamine Salts), a Drug Approved for Attention Deficit Hyperactivity Disorder (ADHD) in Children |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2005-02-11 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Health Canada has Suspended Market Authorization of ADDERALL XR™ (Amphetamine Salts), a Drug Approved for Attention Deficit Hyperactivity Disorder (ADHD) in Children Check if your household is affected: https://therecallfile.com/recalls/health-canada-has-suspended-market-authorization-of-adderall-xrtm-amph/CANADA-24396
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Featured on Product Hunt
Help support our public safety mission and check out our community launch.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordHealth Canada has Suspended Market Authorization of ADDERALL XR™ (Amphetamine Salts), a Drug Approved for Attention Deficit Hyperactivity Disorder (ADHD) in Children
Related Recalls
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018088 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018088 -
Tires
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018288 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018288 -
Airbag
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018409 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018409 -
Airbag
—TC